|
|
Volumn 352, Issue 16, 2005, Pages 1633-1636
|
|
A new colonialism? - Conducting clinical trials in India
a a |
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ERYTHROMYCIN;
G4 N;
LETROZOLE;
M4 N;
TADALAFIL;
TUBERCULOSTATIC AGENT;
UNCLASSIFIED DRUG;
ANTINEOPLASTIC ACTIVITY;
CLINICAL RESEARCH;
CLINICAL TRIAL;
CONTRACEPTION;
COST BENEFIT ANALYSIS;
DRUG COST;
DRUG EFFECT;
DRUG INDUSTRY;
DRUG MECHANISM;
DRUG RESEARCH;
ERECTILE DYSFUNCTION;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
INDIA;
INFORMED CONSENT;
MOUTH CANCER;
POLITICAL SYSTEM;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
RESEARCH ETHICS;
RESEARCH SUBJECT;
REVIEW;
TUBERCULOSIS;
BIOMEDICAL AND BEHAVIORAL RESEARCH;
CLINICAL TRIALS;
COLONIALISM;
DRUG APPROVAL;
DRUG COSTS;
DRUG EVALUATION;
DRUG INDUSTRY;
HUMANS;
INDIA;
INFORMED CONSENT;
INTERNATIONALITY;
|
|
EID: 17244367345
PISSN: 00284793
EISSN: None
Source Type: Journal
DOI: 10.1056/NEJMp048361 Document Type: Review |
|
Times cited : (153)
|
|
References (5)
|
